HDAC inhibitors for cancer chemoprevention

被引:0
|
作者
Muriel, C. [1 ]
机构
[1] Univ Geneva, Univ Lausanne, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland
关键词
D O I
暂无
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
IL33
引用
收藏
页码:864 / 864
页数:1
相关论文
共 50 条
  • [31] HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
    Maccallini, Cristina
    Ammazzalorso, Alessandra
    De Filippis, Barbara
    Fantacuzzi, Marialuigia
    Giampietro, Letizia
    Amoroso, Rosa
    PHARMACEUTICALS, 2022, 15 (06)
  • [32] Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
    Nakashima, Hiroshi
    Nguyen, Tran
    Chiocca, Ennio Antonio
    ONCOLYTIC VIROTHERAPY, 2015, 4 : 183 - 191
  • [33] HDAC Inhibitors as Novel Anti-Cancer Therapeutics
    De Souza, Cristabelle
    Chatterji, Biswa P.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2015, 10 (02) : 145 - 162
  • [34] Autophagic and Apoptotic Effects of HDAC Inhibitors on Cancer Cells
    Rikiishi, Hidemi
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [35] Recent advancement of HDAC inhibitors against breast cancer
    Mehmood, Syed Abdulla
    Sahu, Kantrol Kumar
    Sengupta, Sounok
    Partap, Sangh
    Karpoormath, Rajshekhar
    Kumar, Brajesh
    Kumar, Deepak
    MEDICAL ONCOLOGY, 2023, 40 (07)
  • [36] Circumvention of TKI resistance with HDAC inhibitors in lung cancer
    Yano, Seiji
    ANNALS OF ONCOLOGY, 2015, 26 : 19 - 19
  • [37] Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics
    Tasneem, Sharba
    Alam, Mohammad Mumtaz
    Amir, Mohammad
    Akhter, Mymoona
    Parvez, Suhel
    Verma, Garima
    Nainwal, Lalit Mohan
    Equbal, Ashif
    Anwer, Tarique
    Shaquiquzzaman, Mohammad
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2022, 22 (12) : 1648 - 1706
  • [38] Aromatase inhibitors for chemoprevention
    Goss, PE
    Strasser-Weippl, K
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (01) : 113 - 130
  • [39] Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer
    Mao, Jenny T.
    Cui, Xiaoyan
    Reckamp, Karen
    Liu, Ming
    Krysan, Kostyantyn
    Dalwadi, Harnisha
    Sharma, Sherven
    Hazra, Saswati
    Strieter, Robert
    Gardner, Brian
    Dubinett, Steven M.
    CLINICAL LUNG CANCER, 2005, 7 (01) : 30 - 39
  • [40] Chemoprevention of prostate cancer - the role of 5 alpha reductase inhibitors
    Parekh, D.
    EJC SUPPLEMENTS, 2010, 8 (02): : 4 - 4